Artax Biopharma to present on first-in-class Nck modulator at the 2025 AAD Annual Meeting
Dr. Chris VanDeusen, Chief Scientific Officer, will present “TCR-Nck Modulators: Pioneering Oral Modulation of T Cell Receptor Activation Holding the Promise of Treating Dermatologic Diseases,” ...
Business Insider11d
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
March 07, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announced the presentation of new ...